Get access

The Pharmacokinetic Profile of the Combination of Naproxen and Tizanidine in Rat

Authors

  • Selene Isabel Patiño-Camacho,

    1. Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, México D.F., México
    Search for more papers by this author
  • María Guadalupe Lozoya Moreno,

    1. Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, México D.F., México
    Search for more papers by this author
  • Francisco Javier Flores-Murrieta,

    1. Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, México D.F., México
    2. Instituto Nacional de Enfermedades Respiratorias, Secretaria de Salud, Unidad de Investigación en Farmacología, México D.F., México
    Search for more papers by this author
  • Myrna Déciga-Campos

    Corresponding author
    • Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, México D.F., México
    Search for more papers by this author

  • Support information: SIP-IPN 20110653 and 20121184 grant (MD-C).

Correspondence to: Myrna Déciga-Campos, Sección de Estudios de Posgrado e Investigación, Instituto Politécnico Nacional., Plan de San Luis y Díaz Mirón s/n Col. Santo Tomas, Delegación Miguel Hidalgo. C.P. 11340, México D.F., México.

E-mail: myrnadeciga@hotmail.com; mdeciga@ipn.com.mx

Abstract

Preclinical Research

Naproxen is an anti-inflammatory drug used in a variety of anti-inflammatory syndromes. There is evidence showing that tizanidine enhances the anti-inflammatory effect in rats. This study examines the pharmacokinetics of naproxen when it is combined with tizanidine. Combining these two drugs is an attractive modality for inflammation complaints. Oral coadministration of naproxen/tizanidine produced a synergistic anti-inflammatory effect in rats. The swelling of the rat paw was measured by a plethysmometer using carrageenan as an inflammatory agent. In this study, rats received oral doses of naproxen (1, 3, and 4.2 mg/kg), and these doses were combined with a fixed dose of tizanidine (0.01 mg/kg). To evaluate the pharmacokinetic interaction between naproxen/tizanidine, blood samples were obtained at selected times in the 24 h after oral administration and were analyzed using a validated high-performance liquid chromatography method. Systemic administration of naproxen alone or in combination with tizanidine produced a dose-dependent anti-inflammatory effect. In the pharmacokinetic interaction study, no statistically significant difference was observed for the naproxen concentration-time profiles in the presence of tizanidine. The experimental findings suggest that systemic tizanidine is able to increase the naproxen-induced anti-inflammatory effect in rats. This effect was not due to a modification of the bioavailability of naproxen.

Ancillary